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Abstract
Rationale Anhedonia is a core symptom of major depres-
sion. Deficits in reward function, which underlie anhedo-
nia, can be readily assessed in animals. Therefore,
anhedonia may serve as an endophenotype for understand-
ing the neural circuitry and molecular pathways underlying
depression.
Objective Surprisingly, there is scant knowledge regarding
alterations in brain reward function after olfactory bulbec-
tomy (OB), an animal model which results in a behavioural
syndrome responsive to chronic antidepressant treatment.
Therefore, the present studies aimed to assess reward
function after bulbectomy.
Materials and methods The present study utilized sucrose
preference, cocaine-induced hyperlocomotion and intra-
cranial self-stimulation (ICSS) responding to examine
reward processes in the OB model.
Results Bulbectomized animals showed a marked prefer-
ence (>90%) for 0.8% sucrose solution compared with
water; similar to the preference exhibited by sham controls.
Importantly, there were pronounced deficits in brain reward
function, as assessed using ICSS, which lasted 8 days
before returning to baseline levels. Furthermore, bulbec-
tomized animals were hyper-responsive to the locomotor
stimulating properties of an acute and a repeated cocaine
regimen. However, no difference in ICSS facilitation was
observed in response to an acute cocaine injection.
Conclusions Taken together, these results suggest that
bulbectomized rats display alterations in brain reward
function, but these changes are not long-lasting and thus,
not amenable to investigating the effects of pharmacolog-
ical interventions. However, given that OB animals are
hypersensitive to drugs of abuse, bulbectomy may be an
appropriate inducing factor for the development of animal
models of co-morbid depression and drug dependence.
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Affective disorders represent some of the most common and
proliferating health problems worldwide. Major depression is
predicted to become the second most common cause of global
disease burden by 2020 (Murray and Lopez 1997), and
lifetime prevalence rates are approximately 15% (Kessler et
al. 2005). Unlike many diseases with clearly defined
symptomology, major depression is a heterogeneous disor-
der, classified based on a cluster of symptoms described by
the Diagnostic and Statistic Manual of Mental Disorders
(DSM-IV) and International Classification of Diseases (ICD-
10). Therefore, there have been considerable clinical and
preclinical research efforts to determine the underlying
pathophysiology of depression to gain better insight into
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the disease. Of central importance to this approach is the
availability of valid preclinical animal models for evaluation
of the potential utility of novel pharmacotherapies.
The wide spectra of disruptions that characterize
depression highlight the difficulty posing researchers to
mimic the disorder in the laboratory. Nonetheless, numer-
ous attempts have been made to create rodent models of
depression, or at least model aspects of depression that are
expressed as physiological and behavioural responses.
Despite major differences in brain anatomy between
rodents and humans, there are evolutionary conserved
circuits between species, which underlie certain physiolog-
ical and behavioural responses (Cryan and Holmes 2005).
Thus, largely through inference, we can study these
responses to elucidate behaviours and the neural circuits
and genetic factors subserving them as a means to use
lower species to understand human behaviour and disease.
More recently, it has become clear that a useful strategy
might be to model single endophenotypic differences (i.e.
one clearly defined behavioural output) relevant to the
disease state as opposed to a syndrome (Cryan and Holmes
2005; Cryan and Mombereau 2004; Gould and Gottesman
2006). Endophenotypes can be neuropsychological, cogni-
tive, neurophysiological, neuroanatomical or biochemical in
nature. In parallel, similar efforts have been made for
dissecting various psychiatric disorders into specific endo-
phenotypes (Gould and Gottesman 2006; Hasler et al.
2004). These more discrete clinical features potentially
provide a more effective approach to identifying the genetic
and neurobiological underpinnings of human disease and
represent more tractable entities to model aspects of
psychiatric disorders in animals.
Anhedonia, or the loss of pleasure or interest in previously
rewarding stimuli, is one of the core symptoms of major
depression. Moreover, it is one of the few symptoms which
can be probed in animals, and therefore, can serve as an
appropriate endophenotype for understanding the neural
circuitry and molecular pathways underlying the disease.
Themesolimbic dopamine brain circuit is known to be a major
component of the brain reward system (Kornetsky 2004;
Nestler 2005; Wise 2002), and dysfunctions of this system
contributes to anhedonia (Markou et al. 1998). Although
there has not been substantial research of the brain reward
system in depression, a number of recent studies have used
psychostimulants as a method to probe this system. These
studies demonstrate a hypersensitivity of reward processes to
an acute low dose of psychostimulant in depressed patients
(Naranjo et al. 2001; Tremblay et al. 2002, 2005).
To develop a model of any endophenotype, an appro-
priate inducing factor and a robust behavioural measure are
required (Geyer and Markou 2000). A number of tech-
niques exist to study behavioural consequences of alterations
in reward circuits preclinically, but paramount among these
is intracranial self-stimulation (ICSS). The utility of ICSS is
based on a number of facts: (1) There is no satiation or
tolerance to the stimulation; (2) responding remains stable
for long periods of time and (3) it by-passes sensory inputs
(Kornetsky 2004; Markou and Koob 1992; Wise 2005). A
number of brain regions that support ICSS responding in
rodents have also been demonstrated in human neuro-
imaging studies to have altered activity in major depressed
patients i.e. the hippocampus (Sheline et al. 2002; van der
Kooy et al. 1977) and amygdala (Drevets 2001; Touzani and
Velley 1998). Therefore, ICSS responding may represent a
useful behavioural measurement of the brain reward
function with which to study depression preclinically.
The bilateral surgical removal of the olfactory bulbs
results in a constellation of behavioural, neurochemical and
neuroendocrine changes that are selectively reversed by
chronic, but not acute, antidepressant treatments (Cryan et
al. 1998, 1999; Harkin et al. 2003; van der Stelt et al.
2005). This model has one of the best preclinical profiles
for assessing the effects of novel antidepressant agents
(Cryan et al. 2002). Therefore, the similarity of the deficits
observed and the timeframe of their reversal with that of
humans make the olfactory bulbectomy (OB) model very
attractive for further elucidation of the pathophysiology of
depression. Surprisingly, there is scant knowledge regard-
ing alterations in the brain reward system after OB. The
most robust behavioural phenotype observed after bulbec-
tomy is hyperactivity in a novel environment (see Song and
Leonard 2005 for review). Therefore, given that locomotor
activity is dependent on dopaminergic activity (Kuczenski
et al. 1983), it is suggestive of an altered dopaminergic
system after bulbectomy, which in turn may affect brain
reward function.
Therefore, the aims of the present studies were to
promote a greater understanding of the brain reward system
in the OB model of depression. To achieve this goal, we
utilized three behavioural paradigms: sucrose preference,
intracranial self-stimulation (ICSS) and the hyperlocomotor
response to acute and repeated psychostimulant (i.e.
cocaine) administration in the rat. These procedures enable
assessment of the brain reward system under both basal and
stimulated conditions. Furthermore, the use of ICSS, which
does not require intact sensory inputs, enables study of the
reward system in the bulbectomized rat without any
possible negating influence of the loss of olfaction. Finally,
we assessed the psychomotor and ICSS-facilitating re-
sponse to a challenge dose of cocaine in bulbectomized and
sham-operated rats to assess the response of these animals
to a drug of abuse. It has been hypothesized that
psychomotor stimulant properties of drugs, such as cocaine,
indirectly reflect reward processes of these drugs (Wise and
Bozarth 1982, 1985). Our hypothesis is that there would be
deficits in reward function in the OB model.
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Materials and methods
Animals
Male Sprague–Dawley rats (Charles River, France) weigh-
ing between 270–350 g at the time of surgery were used in
these studies. The animals were housed in groups of two or
four and maintained on a 12-h light/dark cycle (lights on
6:00 A.M.) in a temperature-controlled colony (22–24°C).
The animals had free access to food and water. Animals
were allowed to habituate for at least 7 days before surgery.
All experimental procedures were subject to institutional
review and conducted in accordance with the Veterinary
Authority of Basel-Stadt, Switzerland.
Olfactory bulbectomy
Bilateral olfactory bulbectomy was carried out under
isoflurane anaesthesia (1–3% isoflurane, oxygen flow rate
450–500 CCM). Pre-operative analgesia (buprenorphine
0.1 mg/kg, s.c.) was administered 30 min before surgery.
After anaesthesia, a midline incision was made from
approximately 1 cm posterior to 1 cm anterior to bregma.
Burr holes, ∼2 mm in diameter, were then carefully drilled
through the skull at approximately 7 mm anterior to bregma
and 2 mm on either side of the midline. The olfactory bulbs
were then gently removed by suction with care taken not to
damage the cortex. Finally, the burr holes were filled with
haemostatic sponge and the wound closed with surgical
thread under aseptic conditions. Antiseptic liquid was
applied liberally to the wound, and then the animals were
returned to clean cages. Sham animals were treated in a
similar manner; however, the bulbs were not aspirated.
After surgery, the rats were returned to their home-cage; no
cage contained two bulbectomized rats to minimize any
enhanced intermale aggression that can arise (Kelly et al.
1997). Animals were housed in cages of 2–4 after surgery.
The animals were given 14 days to recover from surgery
before the start of behavioural testing and were handled and
weighed daily to eliminate aggressiveness (Kelly et al.
1997).
Sucrose preference
After 14 days of recovery, animals were transferred into single
housing with free access to food. Each rat was provided with
two water bottles on the extreme sides of the cage during the
24-h training phase to adapt the rats to drinking from two
bottles. After training, one bottle was randomly switched to
contain 0.8% sucrose solution, a concentration shown in
preliminary studies to provide a robust but not maximal sucrose
preference (Slattery and Cryan, unpublished), midway through
the light cycle (12:00–13:00), and 24 h later, the bottles were
reversed to avoid perseveration effects. After another 24 h, the
0.8% sucrose solution bottle was replaced with water, and
drinking was measured for 24 h before one of the two bottles
was removed from the cage. The use of a 48-h testing period
allowed us to preclude any effects of neophobia, artefactual
bias toward any one side and perseveration effects. Further, it
provides information regarding long-term access to a reward-
ing stimulus.
Effect of olfactory bulbectomy on cocaine-induced
hyperactivity
Two days after the conclusion of the sucrose preference,
rats were assessed for locomotor activity during seven
consecutive days in a separate room from where they were
housed. Locomotor activity was assessed in a novel
environment as previously described (Slattery et al.
2005a). An activity monitor consisting of a black and
white video camera was mounted in the top-centre of an
enclosure (60×40×50 cm), whereby a cage (55×33×
19 cm) was positioned in the enclosure. Each second, a
single video frame was acquired with a highly accurate,
programmable, monochrome frame grabber board (Data
Translation, Marlboro, MA, USA; type DT3155). Using in-
house developed software, digitized pixels of two succes-
sive frames were compared, and the total number of pixels
with altered intensity was counted (independently for pixels
with increased and decreased intensity). This allowed the
detection of the animal’s position within the cage (the
centre of the pixels with decreased intensity, because
animals were dark compared with background). All test
sessions were performed during the early phase of the light
cycle (between 08:00–12:00).
Locomotor activity was assessed during a 90-min period,
including a 30-min habituation period before vehicle (0.9%
saline solution) or cocaine (10 mg/kg) injection (1 ml/kg i.p.).
At the end of the 90-min test period, rats were returned to their
home-cages. After the 7-day repeated cocaine administration
period, rats were weighed daily in their home-cage, and
17 days later, all rats were subjected to a challenge dose of
cocaine (5 mg/kg; 1 ml/kg i.p.). Similar to the previous
cocaine injections, rats were habituated to the environment for
30 min before injection of cocaine, and the activity was
monitored for another 60 min.
ICSS electrode implantation
Rats were anaesthetized with an isoflurane–oxygen vapor
mixture (1–3% isoflurane, oxygen flow rate 450–
500 CCM) and secured in a stereotaxic frame (TSE
Systems). The rats were prepared with a stainless steel
bipolar electrode with a diameter of 0.25 mm (MS303/2,
Plastics One) cut to 11 mm in length into the medial
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forebrain bundle at the level of the posterior lateral
hypothalamus (AP-0.5 mm from bregma; ML±1.7 mm;
DV −8.3 mm from dura with the incisor bar at +5 mm
above the interaural line). The electrode was anchored to
four stainless steel skull screws (Plastics One) using dental
acrylic. Animals were allowed to recover for at least 7 days
before undergoing ICSS training.
ICSS apparatus
The experimental apparatus consisted of eight Plexiglas
chambers (30.5×30×17 cm; Med Associates) encased in
sound-attenuated Coulbourn boxes. The chamber consisted
of a stainless steel grid floor and a metal wheel manipu-
landum located on one of the shorter walls, which required
a 0.2-N force to rotate it a quarter turn. Optical sensors
determined when the wheel rotated 90°. Gold-contact
swivel commutators (SL2C two-channel commutator, Plas-
tics One), and bipolar leads (305–305 TT(CS), Plastics
One) connected the animals to a constant current stimulator
(Stimtek 1200, San Diego Instruments, San Diego, CA),
which in turn was controlled via a DOS-based program
(term52) on a PC. The stimulation parameters, data
collection and all programming functions were controlled
by the computer program.
ICSS procedure
A discrete-trial ICSS procedure was used (for details see
Cryan et al. 2003; Markou and Koob 1992, 1993; Slattery
et al. 2005b) that provided current-intensity thresholds, a
measure of reward (Kornetsky and Esposito 1979; Markou
and Koob 1992, 1993).
Training phase A separate group of rats from the sucrose
preference and cocaine-induced hyperactivity experiments
were trained on a fixed ratio 1 schedule of reinforcement to
turn the wheel 90°, which resulted in the delivery of a train
of electrical pulses (typically for a naïve rat comprising of a
100-ms train of pulses of 150 μA with an inter-pulse
interval of 0.1 ms). After successful acquisition of this
reinforcement schedule (two sessions of 100 reinforcers in
less than 5 min), the outside of discrete-trial procedure was
initiated. Each trial was initiated by the delivery of a non-
contingent electrical stimulus that was determined to be
rewarding for the rats during the initial screening phase on
ICSS. The rat had 7.5 sec to respond to receive a second
electrical stimulus, identical in all parameters to the non-
contingent stimulus. After the rat's response or after the 7.5
sec response window, whichever occurred first, an intertrial
interval was initiated that varied in duration from 7.5-12.5
sec. Responding during the intertrial interval postponed the
initiation of the next trial by 12.5 sec.
After successful training in the above procedure, the
current intensity of the non-contingent stimuli, as well as
that of the subsequent earned stimuli, was systematically
varied, changing 10 μA at a time. Current intensities were
initially decreased until the animal was no longer respond-
ing for two successive stimulus intensities, then increased
until the animal responded for two successive stimulus
presentations, and then decreased again until the subject did
not respond for two successive current intensities. This
sequence was repeated twice resulting in three descending
and three ascending series, with descending and ascending
series alternating. There were three trials within each
current intensity. Responses in two out of three trials at a
given current intensity were considered a positive response,
while no responses in two out of the three trials were
considered a negative response (for further details of the
procedure, see Markou and Koob, 1992, 1993).
Mean ICSS response thresholds For each test session, six
thresholds were calculated, and the mean value was taken
as the mean session threshold. The average of the ascending
or descending thresholds were calculated separately, as it
has been shown previously that certain manipulations can
preferentially affect one or other of these measures (Fibiger
and Phillips 1981).
ICSS response latency The latency of response was
measured, which comprised of the interval between the
initiation of the non-contingent stimulus and the operant
response of the rat. An average was calculated for each
ICSS session to provide a mean latency response time.
After 2 to 4 weeks of daily testing, this threshold is
generally stable (less than 10% standard deviation from the
previous 3 days), at which time, manipulations could begin.
Extra responses Additional 90˚ turns of the wheel manip-
ulandum during the 2 s immediately after a positive
response (a response during the 7.5 sec response window)
were counted as extra responses. The total extra responses
per session were calculated.
Time-out responses Responses on the wheel manipulandum
after the end of the 7.5 sec response window and during the
time-out interval were counted as time-out responses. The
total number of time-out responses per session were
calculated.
Effect of olfactory bulbectomy on ICSS responding
Once stable ICSS baseline thresholds were achieved, sham
or olfactory bulbectomy surgery was performed as de-
scribed above. The day after surgery, rats were returned to
the ICSS chamber and their responding assessed daily for
558 Psychopharmacology (2007) 190:555–568
13 or 14 days. As ICSS responding may become unstable
and drift when animals are not presented with their daily
ICSS session, it was important to continue the testing of the
animals from the day after surgery. It has been reported that
some of the behavioural alterations post-bulbectomy only
emerge 2 weeks after surgery (see Kelly et al. 1997).
However, given the well-documented cognitive impair-
ments after bulbectomy, it would not be possible to wait
2 weeks, as it would have been impossible to distinguish
such cognitive deficits from any potential alterations in
reward given that the performance of the operant requires
instrumental learning ability. As there is no sensitization to
the ICSS procedure, we will be able to document any
alteration in reward function after bulbectomy in a temporal
manner where we hypothesized that maximal impairments
would arise 14 days after surgery. Hence, it was important
to continue ICSS threshold assessment to prevent thresh-
olds from drifting if a delay is introduced and to assess
possible development of anhedonic effects during the days
post-surgery. On the 14th (four sham-operated rats and two
OB rats) or 15th (ten sham-operated rats and seven OB
rats) day post-surgery, all responses had returned to pre-
surgery baseline levels between groups. At this point,
animals were administered 7.5 mg/kg cocaine (1 ml/kg, i.
p.) 10 min before the ICSS test to examine responding after
a psychostimulant challenge. The dose of cocaine was
selected from previous studies showing a robust facilitation
of ICSS responding at this dose of cocaine (Mague et al.
2005; Slattery et al. 2005b).
Olfactory bulbectomy verification
At the completion of the behavioural testing, all rats were
killed and their brains were dissected to assess the validity
of the surgery. A correct bulbectomy was defined as the
absence of the bilateral olfactory bulbs without damage to
the frontal cortex. Subjects with incomplete or unilateral
bulb removal and/or cortical damage were excluded from
analysis. Two rats in the ICSS experiment and two rats in
the sucrose/cocaine experiment were excluded on this
basis.
Data analyses
Repeated measures analysis of variance (ANOVA) was
carried out on all variables in the cocaine-induced hyper-
activity and basal ICSS experiments. For ICSS, thresholds
on the ascending series, thresholds on the descending
series, latency, time-out responses and extra responses were
expressed as a percentage of the baseline values assessed
during the 3 days before surgery. Assessment of the sucrose
preference and cocaine facilitation of ICSS responding test
was performed using a Student’s t test. Any overall
statistical differences, which were set at p<0.05, were
further analysed using Fisher’s least significant difference
post hoc. All data were analysed using the SPSS v12
software statistical package.
Results
Olfactory bulbectomy effects on sucrose preference
and cocaine-induced hyperactivity
Body weight
Olfactory bulbectomy resulted in an acute weight loss after
surgery [day × group F(42, 820) = 2.048, p<0.001]. Post-
hoc analysis demonstrated that bulbectomized rats signifi-
cantly lost weight in the first 4 days after surgery compared
with sham-operated controls. Thereafter, bulbectomized rats
gained weight, but at a slower rate than sham controls (data
not shown).
Sucrose preference
Sucrose preference is frequently used as a measure of
anhedonia in rodents (Craft and Devries 2006; El
Yacoubi et al. 2003; Grippo et al. 2006; Strekalova et al.
2004; Willner 1997). At the beginning of the sucrose
preference test (i.e. after 14 days recovery from surgery)
there was no longer a significant difference in body weight
gain observed between the groups [weight gain: sham,
48.12±5.47 g; OB, 34.1±8.1 g; t(20) n.s.]. During the
initial training phase, to accustom the rats to drinking from
two bottles (both filled with water), no significant
difference was observed in water intake between sham
and OB rats [t(20) = −0.281, n.s.]. Total sucrose intake
during the subsequent 48-h presentation of 0.8%
sucrose solution or water did not differ between the
groups [t(20) = 0.927, n.s.]. Similarly, no difference in
total water intake during this time was observed [t(20) =
−1.158, n.s.]. When the percent sucrose preference was
assessed, analysis revealed no significant difference in
preference between sham-operated controls and OB rats
[t(20) = 0.903, n.s.] (see Fig. 1).
Novelty and cocaine-induced hyperactivity
One of the most reliable and widely used behavioural
measures of the OB syndrome is hyperactivity in a novel
environment. Statistical analyses were performed on the
baseline (i.e. initial 30 min in locomotor chamber) data and
cocaine-induced activity (i.e. 30 to 90 min in locomotor
chamber) with day representing the within-subjects vari-
able. Baseline activity was shown to be significantly greater
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in olfactory bulbectomized rats compared with sham
controls [main effect of surgery; F(1,18) = 5.5, p<0.05].
Cocaine treatment also affected baseline activity [main
effect of treatment; F(1, 18) = 4.496, p<0.05], but there
was no interaction effect [F(1,18) = 1.664, n.s.]. Further
analyses revealed a day × surgery interaction effect [F
(7,126) = 4.772, p<0.001], but no day × treatment
interaction effect [F(7,126) = 1.942, n.s.]. Post-hoc analy-
ses demonstrated that on day 1 and on the cocaine
challenge day, bulbectomized rats exhibited hyperlocomo-
tion compared with sham controls (Fig. 2).
As expected, cocaine administration (10 mg/kg) caused
a hyperlocomotor effect in both sham and bulbectomized
rats [main effect of treatment; F(1, 17) = 34.357, p<0.001].
Additionally, a significant effect of surgery on cocaine-
induced activity was observed [surgery; F(1,17) = 6.12,
p<0.05], and there was a significant surgery × treatment
interaction [F(1, 17) = 4.794, p<0.05]. Further analyses
revealed a significant day × treatment interaction [F
(7,119) = 5.127, p<0.001], but no day × surgery
interaction [F(7,119) = 0.824, n.s.] or day × surgery ×
treatment interactions [F(7,119) = 1.329, n.s.]. Post hoc
analyses revealed that cocaine induced hyperactivity on
days 2 to 7 in sham controls compared with vehicle
administration. Similarly, cocaine was shown to induce
hyperactivity in olfactory bulbectomized rats compared
with vehicle administration at all time-points, except
from the initial exposure to cocaine (Fig. 2).
Separate statistical analyses were performed for each day
individually, with time (10-min activity bins) comprising
the within-subjects variable. Significant ANOVA effects of
time and treatment were observed on each individual day,
whereas surgery effects were observed on day 4 and the
challenge day. Furthermore, significant surgery × treatment
interaction effects could be demonstrated on the challenge
day [F(1,18) = 12.293, p<0.01]. Post-hoc analyses, were
appropriate after a significant overall ANOVA effect,
revealed significant effects of both treatment and surgery
on locomotor activity, with bulbectomized rats displaying
hyperactivity in the novel environment and also in response
to cocaine administration both during the repeated admin-
istration regimen and to the challenge dose (Fig. 3).
Olfactory bulbectomy effects on intracranial self-
stimulation responding
When stable 3-day ICSS threshold baselines were achieved,
rats were randomly allocated to sham or olfactory bulbec-
tomy surgery after the final day’s ICSS session. Olfactory
bulbectomy resulted in significant changes to all parameters
measured during ICSS sessions. During the initial 4 days, a
subset of bulbectomized rats did not complete two
consecutive discrete-trial series to obtain daily threshold
values (six on day 1, five on day 2, three on day 3 and one
on day 4) and were not included in statistical analyses for
thresholds (A to C). However, these animals did complete a
sufficient number of reinforced trials to include in response
latency and extra response analyses. Similarly, time-out
responses were monitored and included in analyses for all
days. Thereafter, all rats responded during their daily ICSS
session.
Body weight
As seen in experiment 1, olfactory bulbectomy resulted
in a moderate yet significant weight loss, which was
maximal 3 days after surgery [repeated measures: surgery
F(1,15) = 37.365, p<0.001; surgery × day F(18,270) =
19.196, p<0.001]. Post-hoc analysis revealed that olfactory
bulbectomized rats gained less weight over the entire
duration of the ICSS experiment, although this appeared
to be due to the initial weight loss (Fig. 4).
Thresholds
Mean ICSS threshold were significantly elevated after
bulbectomy [main effect of surgery F(1, 21) = 14.385,
p<0.001; main effect of day F(13, 298) = 10.141, p<0.001;
Fig. 1 The effect of surgery on
total water, total sucrose and
percent sucrose preference vari-
ables during the 48-h sucrose
preference paradigm and water
intake during the 24-h training
phase. Data represent mean±
SEM. Student’s t test was per-
formed between the two groups
on the variables. There were no
differences in any variable
assessed
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Fig. 2 Effect of bulbectomy on
baseline and cocaine-induced
locomotor activity in the rat.
A–H represent days 1 to 7 and
the challenge day baseline
locomotor activity i.e. the total
locomotion in the initial 30-min
testing, respectively. A′–H′
represent days 1 to 7 and the
challenge day of total cocaine-
induced locomotor activity
(60 min), respectively. Two-way
repeated-measures ANOVA fol-
lowed by Fisher’s post-hoc was
performed. An asterisk indicates
p<0.05, two asterisks indicate
p<0.01 and three asterisks in-
dicate p<0.001 compared with
relevant surgery group. Number
symbol indicates p<0.05 and
two number symbols represent
p<0.01 compared with relevant
treatment group
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interaction effect of surgery × day F(13, 298) = 7.812,
p<0.001]. Post-hoc analysis revealed that bulbectomy
resulted in an initial elevated mean threshold, which normal-
ized over the course of testing (by day 8; Fig. 5a). As has
been shown previously, manipulations can selectively affect
either the ascending or descending reward thresholds
derived from the ICSS procedure (Fibiger and Phillips
1981). Thus, we investigated if this was the case after
bulbectomy. As can be seen in Fig. 5b and c, when the mean
threshold was broken down into ascending and descending
means, differences between the groups were also observed.
Ascending mean threshold values were significantly increased
by bulbectomy surgery [main effect of surgery F(1, 21) =
14.697, p<0.001; main effect of day F(13, 298) = 13.053,
p<0.001; interaction effect of surgery × day F(13, 288) =
8.137, p<0.001], as were descending mean threshold
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Fig. 3 The effect of olfactory bulbectomy on cocaine-induced hyper-
locomotion and cocaine challenge. D1–D7 and C represent day 1–7
and challenge day 10-min activity bins, respectively. Data represent
mean±SEM. Two-way repeated-measures ANOVA followed by
Fisher’s post hoc was performed for each dataset. An asterisk
indicates p<0.05, two asterisks indicate p<0.01 and three asterisks
indicate p<0.001 compared with relevant surgery group. Number
symbol indicates p<0.05, two number symbols indicate p<0.01 and
three number symbols indicate p<0.001 compared with relevant
treatment group
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values [main effect of surgery F(1, 21) = 10.7, p=0.004;
main effect of day F(13, 298) = 10.411, p<0.001;
interaction effect of surgery × day F(13, 295) = 6.268,
p<0.001]. Post-hoc analysis revealed that bulbectomized
rats exhibited elevated ascending and descending mean
thresholds during the initial days after surgery (Fig. 5b
and c).
Latency
OB also altered the response latency [main effect of surgery
F(1, 21) = 0.081, n.s.; main effect of day F(13, 312) =
4.092, p<0.001; interaction effect: surgery × day F(13,
312) = 2.246, p=0.01]. Further analysis showed that
bulbectomized rats displayed an increase in latency com-
pared with sham-operated controls and with their own
presurgery baselines (Fig. 5d).
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Fig. 5 The effects of olfactory
bulbectomy on ICSS parame-
ters. Olfactory bulbectomized
rats (filled triangle) exhibit al-
teration in a mean threshold,
b ascending threshold,
c descending threshold, d re-
sponse latency, e time-out
responses and f extra responses
compared with sham-operated
controls (filled square). Data
represent mean±SEM values
compared with the 3-day pre-
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RM ANOVA followed by Fish-
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for each dataset. An asterisk
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indicate p<0.01 and three
asterisks indicate p<0.001
compared with sham operated
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Extra responses and time-out responses
Both these measures were altered by surgery [extra re-
sponses, main effect of surgery F(1, 21) = 5.622, p<0.05;
main effect of day F(13, 310) = 6.787, p<0.001; interaction
effect: surgery × day F(13, 310) = 6.196, p<0.001; time-
out responses, main effect of surgery F(1, 21) = 1.299, n.s.;
main effect of day F(13, 311) = 4.991, p<0.001; interaction
effect of surgery × day F(13, 311) = 2.977, p<0.001].
Post-hoc analyses revealed a trend towards an initial
decrease in both responses followed by a significant
increase before normalization in bulbectomized rats (see
Fig. 5e and f).
Effects of acute cocaine on ICSS responding in OB
and sham animals
In response to an acute administration of cocaine (7.5 mg/kg
i.p. 10 min before ICSS session), no significant difference
was observed between the two groups (Fig. 6). However,
there was a tendency for bulbectomized rats to exhibit an
increase in the number of time-out responses (p=0.068).
Discussion
The present studies demonstrate that olfactory bulbectomy
induces pronounced deficits in brain reward function as
assessed using ICSS, which are not long-lasting and
normalize within 14 days. However, bulbectomized animals
have persistent alterations in the locomotor response to the
psychostimulant cocaine. Interestingly, the preference for
sucrose was not altered by bulbectomy. Additionally, the
ICSS threshold-lowering effect of cocaine administration
was not altered in comparison with control rats.
Despite its use as an animal model of depression for
more than 30 years, there is scant knowledge regarding the
alterations that removal of the olfactory bulbs has on brain
reward function. This is surprising, given the fact that
anhedonia is one of the core symptoms of depression, and
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Fig. 6 The effects of olfactory
bulbectomy on cocaine-induced
alterations in ICSS parameters.
No effect of olfactory bulbec-
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anhedonic-like behaviour has been widely utilized in other
animal models of depression, such as chronic mild stress
(Willner 1997). An animal, when given a free choice, will
preferentially consume a sweet sucrose solution over water,
and this can be used to gain insight into the perceived
reward an animal can obtain. In this paper, we demonstrate
that 2 weeks after olfactory bulbectomy, a time when the
behavioural and neurochemical alterations caused by the
manipulation are at their zenith (Harkin et al. 2003; Kelly et
al. 1997; Song and Leonard 2005), no difference in sucrose
preference is observed between surgical groups (Fig. 1).
Furthermore, no significant effect was observed on water or
sucrose intake. These results suggest that under baseline
conditions, with no effort required to obtain a reward,
bulbectomy does not affect the brain reward system that
underlies the intake of a palatable solution. Previous studies
have shown that bulbectomy reduced sucrose preference
(Primeaux et al. 2003) or had no effect in male animals but
did modify responding in female rats (Stock et al. 2000).
However, the former study must be treated with caution, as
only the statistical significance was provided in the
manuscript and not the raw data. Taken together with the
present study, these results suggest that bulbectomy does
not cause a robust shift in the rewarding properties of
sucrose but suggest that females may be more susceptible to
alterations in perceived reward to a palatable solution after
bulbectomy.
Although sucrose preference can provide insight into
brain reward system functioning, administration of a
psychostimulant dopaminergic probe can reveal changes
which occur after a challenge to the system (Naranjo et al.
2001). Many drugs of abuse, for example, have been
demonstrated to increase dopamine release in the nucleus
accumbens, and administration of dopaminergic antagonists
can reduce the rewarding properties of such drugs. Masini
et al. (2004) demonstrated that under basal conditions,
bulbectomized rats displayed increased dopamine release,
as measured by microdialysis, in both the dorsal and ventral
striatum. This effect is consistent with findings indicating
that bulbectomy results in increased locomotor activity in
an open field (Chambers et al. 2004; Cryan et al. 1998,
1999; Masini et al. 2004), as locomotor activity is critically
dependent on activation of dopaminergic neurotransmission
(Kuczenski et al. 1983). Therefore, we assessed challenging
the brain reward system with daily administration of
cocaine and compared locomotor activity between bulbec-
tomized and control rats.
As has been previously described, bulbectomized rats
display hyperactivity in a novel environment (Figs. 2
and 3). This increased ambulation had returned to the level
of the sham-operated controls after 30 min, at which time
point, the rats received a cocaine or saline injection.
Cocaine administration resulted in hyperactivity in both
sham and olfactory bulbectomized rats, which was pro-
longed in bulbectomized rats compared with their respective
controls (Figs. 2 and 3). Hyperactivity is a well-character-
ized response to cocaine administration, and a previous
study has shown that bulbectomized rats have a greater
ambulation to cocaine than sham-operated controls (Cham-
bers et al. 2004). In the present study, we extended these
findings to demonstrate that this effect persisted during the
7-day cocaine administration period and after a final 8th
challenge injection of cocaine after a 17-day withdrawal
period.
Interestingly, on the 7th day of testing, the bulbectomy
cocaine treatment group displayed a greater hyperactivity
during the habituation period compared with controls
(Fig. 3). This effect suggests that the repeated cocaine
administration resulted in persistent alterations to the
dopamine system. Studies in naïve animals have shown
that those displaying greater locomotor activity also exhibit
increased dopamine release in the striatum (Rouge-Pont et
al. 1993). We also demonstrate that bulbectomized rats
display a significantly greater locomotor response to a
cocaine challenge given subsequent to a withdrawal period
from the continuous administration regime. This finding
lends further support to a persistent alteration in the
mesolimbic system after the repeated administration of
cocaine in bulbectomized animals. These findings are also
in agreement with previously reported studies, which show
that bulbectomized rats acquire self-administration of low
amphetamine doses faster than controls (Holmes et al.
2002). Analogously, recent findings from human studies
have shown persistent alterations in the brain reward
system in depressed patients, which engender them hyper-
sensitive to the administration of drugs of abuse. For
example, depression severity was closely correlated with
the rewarding effects of D-amphetamine (30 mg/kg p.o.)
administration, with mild/moderate depressives reacting
similarly to controls, but severely depressed patients
exhibiting a much greater reaction (Naranjo et al. 2001).
Similarly, two studies using dextroamphetamine demon-
strated hypersensitivity in severely depressed patients
(Tremblay et al. 2002; Tremblay et al. 2005). Therefore,
the findings in the current study of cocaine-induced
hyperactivity in bulbectomized rats are comparable and
suggest further study of the underlying circuitry involved in
this phenomenon. Further, given the marked co-morbidity
between drug dependence and depression, our findings are
in agreement with the hypothesis that there are shared
underlying neurobiological substrates between both disor-
ders. Whereas it is evident that the locomotor effects of
stimulant drugs and their reinforcing effects are not
homologous, locomotor activity is critically dependent on
activation of dopaminergic neurotransmission (Kuczenski
et al. 1983). A pivotal role of ventral tegmental area
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dopaminergic neurons in mediating the hyperlocomotor
effects of psychostimulants has been described (Kalivas and
Stewart 1991). Nonetheless, further investigation of the
effects of bulbectomy in animal models of reward and
addiction is necessary.
It is believed that major depression leads to less
reinforcement to reward-related cues and has been shown
to be associated with reduced emotional responsiveness
(Pizzagalli et al. 2005; Shestyuk et al. 2005; Surguladze et
al. 2004). Therefore, given that a rewarding stimulus is
associated with a positive reinforcement, ICSS responding
provides a unique tool with which to concomitantly study
positive reinforcement with an accurate, quantifiable
measurement of the brain reward system. The results
show that there is a dramatic anhedonic-like effect of
bulbectomy during the first week after surgery, as it
resulted in threshold elevations (Fig. 5a–c), reminiscent of
that seen after withdrawal from various psychostimulant
drugs (Barr and Markou 2005; Cryan et al. 2003).
Nonetheless, such a time frame is not sufficient to initiate
a chronic regimen of antidepressant medication and
therefore weakens the utility of the paradigm as a model
for screening novel antidepressant drugs. Furthermore, as
this anhedonic-effect was present during the initial
recovery phase from the surgery, we cannot rule out the
influence of physically removing the olfactory bulbs (see
Fig. 4). Despite the fact that a sham-operated control
group was utilized, this group, by necessity, does not
undergo the same degree of invasive surgery as the
bulbectomy group. Nevertheless, it should be noted that
the threshold elevating effects of olfactory bulbectomy
persisted longer than the increase in response latency seen
after the same manipulation. This observation is signifi-
cant, as it has been shown that manipulations that affect
the motor capabilities of the animal increase response
latencies, decrease extra and time-out responses, but have
no effect on thresholds (Markou and Koob 1992). Thus,
the increase (rather than decrease) in extra and time-out
responses early after the olfactory bulbectomy also argues
against possible motor-impairing effects of olfactory
bulbectomy that may have interfered with responding in
the ICSS task.
Moreover, it is also possible that the initial anhedonic-
like effect observed after bulbectomy could be the result of
a cognitive deficit. The increased number of time-out and
extra responses observed after bulbectomy may give some
credence to this supposition. However, these behavioural
responses could also reflect the increase in impulsivity and
agitation previously reported in both bulbectomy (Lumia et
al. 1992) and depressed patients (Arango et al. 2002).
Furthermore, such alterations in behaviour are probably
driven by changes in the serotonergic system as opposed to
other central reward systems (Hasegawa et al. 2005; Lumia
et al. 1992; Song and Leonard 2005; van der Stelt et al.
2005). This dissociation is further supported by the fact that
the increases observed in these parameters follow a
markedly different temporal pattern to that of the elevated
thresholds, further supporting the concept that these
parameters are functionally distinct.
Finally, to assess the perceived rewarding value of an
acute administration of a drug of abuse in the olfactory
bulbectomy model of depression, the ICSS threshold-
lowering properties of this drug were examined. When
stable ICSS reward thresholds had returned after surgery,
cocaine was administered 10 min before the ICSS session.
As previously demonstrated, cocaine resulted in a robust
threshold-lowering response in control rats (Slattery et al.
2005b) and although there was a trend toward an attenuated
threshold-lowering effect in bulbectomized rats, this did not
reach significance (Fig. 6). This is in stark contrast to the
findings of accentuated cocaine responses on hyperloco-
motor activity in bulbectomized rats. However, separation
between locomotor and rewarding effects of cocaine has
previously been demonstrated in rats (Slattery et al. 2005b).
Furthermore, bulbectomy has previously been demonstrated
to reduce the expression of cocaine-induced place prefer-
ence (Calcagnetti et al. 1996), lending further support for
the dissociation between locomotor and rewarding effects
of cocaine.
The only ICSS parameter analysed which differed
between the groups was a strong trend toward an increase
in time-out responses (p=0.06). This suggests that bulbec-
tomized rats may be more impulsive after administration of
a drug of abuse. As impulsivity is largely under the
regulation of the serotonergic system (Brunner and Hen
1997), this result further reinforces the dissociation between
the neural basis of these responses, which is probably due
to the well-documented alterations in the serotonergic
system in bulbectomized animals (Hasegawa et al. 2005;
van der Stelt et al. 2005) and the altered anhedonia-related
effect.
In conclusion, the present study demonstrates an
anhedonic-like phenotype after olfactory bulbectomy under
basal conditions which is normalized within 2 weeks of
further ICSS testing. Additionally, we show that an acute
challenge with cocaine provides the same level of reward as
assessed with ICSS, whereas cocaine induces a more
pronounced hyperactivity in bulbectomized rats compared
with sham-operated controls. This study demonstrates the
utility of studying singular symptom clusters of major
depression in animal models. Although the olfactory
bulbectomy model mimics numerous aspects of depression
seen in patients, this manipulation does not appear to
induce the long-lasting alterations to the brain reward
system under basal conditions. Therefore, whereas bulbec-
tomy gives significant insights into certain aspects of
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depression and serves to be an appropriate inducing factor
for certain endophenotypes such as cognitive deficits (Kelly
and Leonard 1993; Redmond et al. 1994), alterations in cell
proliferation (Keilhoff et al. 2006), alterations in neuro-
genesis (Jaako-Movits and Zharkovsky 2005), neuroendo-
crine dysfunction (Kelly et al. 1997), amygdala alterations
(Song and Leonard 2005), alterations in neuroimmune
function (Connor et al. 2000) and hypofunctionality of the
serotonergic system (van der Stelt et al. 2005), it appears
unlikely to give such information regarding anhedonia.
Taken together, these results suggest that bulbectomized
rats do display alterations in brain reward function, but
these are not long-lasting and not amenable to the study of
pharmacological intervention. However, given that bulbec-
tomized animals are hypersensitive to drugs of abuse, future
studies will address whether bulbectomy may be an
appropriate inducing factor for the development of animal
models of co-morbid depression and drug dependence.
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